4.6 Review

The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

MiR-181c sensitizes ovarian cancer cells to paclitaxel by targeting GRP78 through the PI3K/Akt pathway

Li-ying Zhang et al.

Summary: The study identified miR-181c as downregulated in PTX-resistant ovarian cancer cells and tissues, which induced apoptosis and inhibited the PI3K/Akt pathway by directly targeting GRP78. Overexpression of miR-181c sensitized resistant ovarian cancer to PTX, suggesting a potential therapeutic strategy.

CANCER GENE THERAPY (2022)

Article Oncology

Factors associated with serum CA125 level in women without ovarian cancer in the United States: a population-based study

Xiao Hu et al.

Summary: This population-based study examines the factors associated with serum CA125 levels in premenopausal and postmenopausal women without ovarian cancer. The results show that current smoking, longer duration of oral contraceptive pill use, and history of non-ovarian cancer are associated with lower CA125 levels in premenopausal women, while coronary artery disease, history of breastfeeding, and elevated CRP levels are associated with higher CA125 levels in postmenopausal women.

BMC CANCER (2022)

Article Oncology

MicroRNA Expression Profiling Predicts Nodal Status and Disease Recurrence in Patients Treated with Curative Intent for Colorectal Cancer

Matthew G. Davey et al.

Summary: This study aimed to evaluate the role of mi(cro)RNAs as biomarkers in predicting nodal status and recurrence in colorectal cancer patients. The results showed that aberrant expression of miR-21 and miR-135b was associated with increased nodal stage, while increased expression of miR-195 predicted the time to disease recurrence. These findings support the use of miRNA expression profiling in personalizing therapeutic decision making.

CANCERS (2022)

Review Medicine, General & Internal

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy

Laura M. Harbin et al.

Summary: Ovarian cancer is a deadly gynecologic malignancy, and precision medicine and molecular biomarker testing can help improve treatment outcomes.

DIAGNOSTICS (2022)

Article Surgery

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer A Prospective, Multicenter Clinical Trial

Matthew G. Davey et al.

Summary: This study demonstrates the potential value of circulating miRNA measurement in predicting response to neoadjuvant chemotherapy (NAC). By analyzing the correlation between miRNA expression trends and treatment response, miRNAs that are associated with NAC response were identified. These findings have the potential to inform personalized treatment decision-making.

ANNALS OF SURGERY (2022)

Article Genetics & Heredity

Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer

Aliaa Talaat et al.

Summary: The study found that miRNA-21 is highly expressed in the serum of ovarian cancer patients and can be used as a tumor marker for the diagnosis and prognosis of ovarian cancer.

EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS (2022)

Article Medicine, Research & Experimental

Identification of Stably Expressed Reference microRNAs in Epithelial Ovarian Cancer

Joanna Lopacinska-Joergensen et al.

Summary: This study aims to identify stable miRNAs based on global microarray profiling of 197 EOC patients and verify their stability in external datasets. Hsa-miR-92b-5p and hsa-miR-106b-3p were identified as stable candidates shared between four datasets. The selection of suitable endogenous miRNA normalization controls in EOC remains unresolved, as variability in miRNA performance between platforms might impact the biological interpretation of data.

IN VIVO (2022)

Article Medicine, General & Internal

MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT

Min Wei et al.

Summary: The research demonstrated that miRNA-101 is down-regulated in ovarian cancer cells and its over-expression can suppress the growth of ovarian cancer cells by inducing apoptosis and cell cycle arrest, potentially through regulating molecules like PTEN, PI3K, and AKT.

ARCHIVES OF MEDICAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

MicroRNA Expression Profiles and Breast Cancer Chemotherapy

Matthew G. Davey et al.

Summary: Breast cancer treatment has evolved from solely relying on radical surgical resection to incorporating chemotherapy, radiotherapy, targeted therapy, and refined surgical approaches. MiRNAs serve as important biomarkers in predicting treatment response, improving therapeutic strategies, and enhancing prognosis for breast cancer patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Medicine, General & Internal

New Predictive Biomarkers for Ovarian Cancer

Ghofraan Abdulsalam Atallah et al.

Summary: Ovarian cancer is often diagnosed in advanced stages due to lack of early symptoms. Surgical debulking and chemotherapy are mainstays of treatment, but chemoresistance is a common issue. Therefore, there is a critical need for identifying new biomarkers to improve diagnosis and prognosis for ovarian cancer.

DIAGNOSTICS (2021)

Review Oncology

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors

Vinitha Richard et al.

Summary: Breast cancer is a heterogeneous disease model with various tumor subtypes, and microRNA profiling plays a significant role in precise classification, prediction of tumor progression, and risk stratification. By integrating protein, gene, and miRNA expression studies, a unique miRNA-based taxonomy is proposed as the gold standard for appropriate classification and separation of breast cancer for targeted therapy.

CANCERS (2021)

Review Oncology

Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications

Khalid Otmani et al.

Summary: MicroRNAs (miRNAs) are important noncoding RNAs that regulate gene expression and play crucial roles in cancer development and progression. They have potential to be specific biomarkers for cancer diagnosis and prognosis, as well as promising approaches for cancer therapy through manipulating tumor suppressive miRNAs.

FRONTIERS IN ONCOLOGY (2021)

Article Reproductive Biology

Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer

Jingjing Liu et al.

Summary: Exosomal miRNA profiling was used to identify potential biomarkers for epithelial ovarian cancer (EOC). The up-regulated miR-4732-5p in plasma derived exosomes showed high sensitivity and specificity in distinguishing EOC patients from healthy subjects, and may serve as a promising candidate biomarker for diagnosing EOC and monitoring disease progression.

JOURNAL OF OVARIAN RESEARCH (2021)

Article Oncology

CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels

Yi-Sheng Wang et al.

Summary: CA125-Tn detected by ELISA assay shows improved specificity in preoperative diagnosis of ovarian cancer, especially in patients older than 45 years, without compromising sensitivity.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Review Oncology

OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis

Matthew G. Davey et al.

Summary: This study compared the OncotypeDX (c) Recurrence Score (RS) between BRCA mutation carriers and patients with sporadic breast cancer, revealing that BRCA carriers were more likely to have a high-risk RS.

EUROPEAN JOURNAL OF CANCER (2021)

Review Oncology

Exploiting epigenetic dependencies in ovarian cancer therapy

Aisling Y. Coughlan et al.

Summary: Ovarian cancer therapy has not seen significant advancements in the past 50 years, with surgery and chemotherapy remaining the main treatments. Alterations in epigenetic regulators are closely associated with ovarian cancer and may serve as therapeutic targets. New models and technologies allow for a better understanding of the epigenetic pathways in ovarian cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment

Matthew G. Davey et al.

Summary: Breast cancer is the most common cancer in women, with improved survival outcomes due to enhanced understanding of molecular processes. Studies on miRNA expression profiles have shown potential in informing breast cancer prognosis and predicting treatment outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

The Role of microRNA Let-7d in Female Malignancies and Diseases of the Female Reproductive Tract

Chiara De Santis et al.

Summary: microRNA let-7d is dysregulated in female malignancies and other pregnancy-associated diseases, affecting various cellular processes and potentially serving as a therapeutic target and diagnostic biomarker.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

MicroRNA-193a-5p exerts a tumor suppressive role in epithelial ovarian cancer by modulating RBBP6

Shuangli Zhang et al.

Summary: The study found that miR-193a-5p expression levels were significantly decreased in serum samples and cell lines of patients with EOC, and RBBP6 was identified as a target gene of miR-193a-5p. The miR-193a-5p mimic significantly inhibited SKOV3 cell proliferation, migration, and invasion, promoting apoptosis, while overexpression of RBBP6 reversed the effects mediated by the miR-193a-5p mimic.

MOLECULAR MEDICINE REPORTS (2021)

Article Reproductive Biology

MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer

Xiaoyuan Lu et al.

Summary: miR-585-3p is significantly down-regulated in HGSOC tissues and cell lines, inhibiting the proliferation and migration of HGSOC cells by targeting CAPN9.

JOURNAL OF OVARIAN RESEARCH (2021)

Review Oncology

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer

Matthew G. Davey et al.

Summary: In breast cancer development, the expression of Ki-67 is a valuable indicator for prognosis and treatment decision making. The advent of molecular medicine has transformed breast cancer management by recognizing the heterogeneity of the disease and using a combination of factors for substratification and personalization of treatment modalities. Routine evaluation of Ki-67 as a proliferation marker in breast cancer patients has limitations, but promising strategies are being explored to enhance its utility in future oncology.

CANCERS (2021)

Article Medicine, Research & Experimental

Determining breast cancer biomarker status and associated morphological features using deep learning

Paul Gamble et al.

Summary: In this study, deep learning systems were developed to predict breast cancer biomarker status using H&E images. The models provided accurate predictions for ER, PR, and HER2 at both slide-level and patch-level, while interpretability analyses identified specific histological features associated with these markers. This approach may offer a cost-effective and efficient way to improve quality control in breast cancer marker detection.

COMMUNICATIONS MEDICINE (2021)

Review Biochemistry & Molecular Biology

Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review

Giacomo Setti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Environmental Sciences

Inhibition of miR-141 and miR-200a Increase DLC-1 and ZEB2 Expression, Enhance Migration and Invasion in Metastatic Serous Ovarian Cancer

Norhazlina Abdul Wahab et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Pharmacology & Pharmacy

MicroRNA-155-5p Diminishes in Vitro Ovarian Cancer Cell Viability by Targeting HIF1α Expression

Ysrafil Ysrafil et al.

ADVANCED PHARMACEUTICAL BULLETIN (2020)

Review Oncology

Prognostic value of let-7 in lung cancer: systematic review and meta-analysis

Cheng Shen et al.

TRANSLATIONAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints

Michael-Antony Lisio et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Ovarian Cancer: An Integrated Review

Christine Stewart et al.

SEMINARS IN ONCOLOGY NURSING (2019)

Review Biochemistry & Molecular Biology

The Influence of Diet on MicroRNAs that Impact Cardiovascular Disease

Branislav Kura et al.

MOLECULES (2019)

Review Environmental Sciences

MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities

San-Nung Chen et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Article Multidisciplinary Sciences

Age-related gene and miRNA expression changes in airways of healthy individuals

J. Ong et al.

SCIENTIFIC REPORTS (2019)

Article Cell Biology

Ovarian Cancer: A Heterogeneous Disease

Myriam Kossai et al.

PATHOBIOLOGY (2018)

Article Multidisciplinary Sciences

The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas

Antonio Agostini et al.

SCIENTIFIC REPORTS (2018)

Review Oncology

Human salivary microRNAs in Cancer

Oscar Rapado-Gonzalez et al.

JOURNAL OF CANCER (2018)

Review Endocrinology & Metabolism

PTEN: Tumor Suppressor and Metabolic Regulator

Chien-Yu Chen et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Article Genetics & Heredity

Identification and Analysis of Human Sex-biased MicroRNAs

Chunmei Cui et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2018)

Review Endocrinology & Metabolism

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

Jacob O'Brien et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Review Oncology

Current and Prospective Protein Biomarkers of Lung Cancer

Tatiana N. Zamay et al.

CANCERS (2017)

Review Medicine, General & Internal

Subtypes of Ovarian Cancer and Ovarian Cancer Screening

Masafumi Koshiyama et al.

DIAGNOSTICS (2017)

Review Medicine, General & Internal

Therapeutics in Cancer - An Emerging Concept

Maitri Y. Shah et al.

EBIOMEDICINE (2016)

Review Biochemistry & Molecular Biology

The role of MicroRNAs in human cancer

Yong Peng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)

Review Biochemistry & Molecular Biology

The Role of miRNA in Papillary Thyroid Cancer in the Context of miRNA Let-7 Family

Ewelina Perdas et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Pharmacology & Pharmacy

Small molecule compounds targeting miRNAs for cancer therapy

Paloma del C. Monroig et al.

ADVANCED DRUG DELIVERY REVIEWS (2015)

Review Biochemistry & Molecular Biology

Smoking and microRNA dysregulation: a cancerous combination

Navneet Momi et al.

TRENDS IN MOLECULAR MEDICINE (2014)

Review Medical Laboratory Technology

The Long Journey of Cancer Biomarkers from the Bench to the Clinic

Maria P. Pavlou et al.

CLINICAL CHEMISTRY (2013)

Article Oncology

Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment

Masato Nishimura et al.

CANCER DISCOVERY (2013)

Review Genetics & Heredity

MicroRNA profiling: approaches and considerations

Colin C. Pritchard et al.

NATURE REVIEWS GENETICS (2012)

Article Biochemistry & Molecular Biology

Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer

Elrasheid A. H. Kheirelseid et al.

BMC MOLECULAR BIOLOGY (2010)

Review Oncology

The Promise of MicroRNA Replacement Therapy

Andreas G. Bader et al.

CANCER RESEARCH (2010)

Article Multidisciplinary Sciences

Circulating microRNAs as stable blood-based markers for cancer detection

Patrick S. Mitchell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemical Research Methods

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

Margaret S. Ebert et al.

NATURE METHODS (2007)

Review Developmental Biology

microRNAs as oncogenes and tumor suppressors

Baohong Zhang et al.

DEVELOPMENTAL BIOLOGY (2007)

Article Obstetrics & Gynecology

Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report

H Kafali et al.

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2004)